Status:
COMPLETED
An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt
Lead Sponsor:
GlaxoSmithKline
Conditions:
Human Papillomavirus Infection
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of the study is to determine the Human Papillomavirus (HPV) prevalence and HPV type distribution among women aged \>= 18 years, attending out-patient health services for gynaecological exa...
Eligibility Criteria
Inclusion
- Women \>= 18 years of age attending a clinic for gynaecological examination.
- Women who agree to provide a cervical sample for human papillomavirus testing.
- Written informed consent obtained from the subject.
Exclusion
- Referral for abnormal cervical sample at the current visit.
- Abundant menstrual bleeding or vaginal discharge not allowing appropriate screening to be performed.
- History of hysterectomy.
- Known diagnosis of immunosuppression, or patient on immunosuppressives.
- Pregnant women.
- Having received one or more doses of HPV vaccine prior to participating in the study.
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
490 Patients enrolled
Trial Details
Trial ID
NCT01158209
Start Date
October 1 2010
End Date
August 1 2011
Last Update
July 16 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Alexandria, Egypt
2
GSK Investigational Site
Cairo, Egypt